- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02781714
Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya (Mobile WACh XY)
Meeting women's need for postpartum family planning is has been acknowledged as a global priority in maternal and child health. The prevention of unintended pregnancies in sub-Saharan African countries, which carry the highest global burdens of maternal mortality and HIV infection, is projected to substantially decrease maternal and neonatal morbidity and mortality. Many barriers to contraceptive uptake exist, both within and outside of the postpartum time period, and include socio-cultural, economic, and supply-side factors. Furthermore, while the importance of engaging men in family planning programs has been acknowledged for decades, few interventions have succeeded in increasing male involvement in family planning while maintaining a focus on women's empowerment. Innovative approaches to meeting the family planning needs of women and couples are urgently needed.
Public health interventions are increasingly incorporating mobile health (mHealth) approaches using short message service (SMS) technology in low-income countries, approaches that have demonstrated benefit among various reproductive health outcomes. The investigators hypothesize that personalized, bidirectional SMS dialogue with individual women and couples will increase postpartum contraceptive uptake, thereby decreasing unmet need for family planning in Kenya. The investigators have collaborated with the University of Washington (UW) Department of Computer Science and Engineering (CSE) along with Kenyan telecommunication providers to develop a hybrid messaging system that allows for innovative bidirectional SMS messaging. This system has been used successfully in maternal child health (MCH) clinics in Kenya. In qualitative research, women in Kenya have expressed a strong desire for mHealth support to provide additional education, counseling and reminders to supplement counseling by health workers.
The investigators propose a randomized controlled trial (RCT) comparing the effects of bidirectional SMS dialogue vs. control on highly effective contraceptive use at 6 months postpartum among HIV negative women and couples in Nyanza Province, Kenya. Data from this RCT and accompanying qualitative study will contribute to innovative, scale-able strategies to address unmet need for contraception and increase male involvement in family planning.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kisumu County
-
Ahero, Kisumu County, Kenya
- Ahero sub-County Hospital
-
-
Siaya County
-
Bondo, Siaya County, Kenya
- Bondo County Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant; at least 28 weeks gestation
- HIV negative
- Daily access to a mobile phone
- Planning to stay in area for 6 months postpartum
- Able to read/write or has trusted person to help
Exclusion Criteria:
- Does not meet above criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Two-way SMS
Pre-programmed SMS messages by partner track will be delivered twice weekly to participants in participants' preferred languages from enrollment to 6 months postpartum.
They will include a question soliciting a response from the participant(s).
Interactive SMS communication will be responded to and managed by the study nurse at each site.
Content themes will include: general support/encouragement, postpartum visit reminders, postpartum pregnancy risk and benefits of birth spacing, postpartum contraceptive options and side effects, family planning misconceptions, and couple communication.
|
SMS messages will provide tailored and actionable education, counseling, and reminders specific to antenatal/postpartum timing and partner track. Messages will include questions and prompts; women and their male partners have the option of writing back to a nurse with questions or concerns, who will provide real-time responses via text and/or make referrals to a clinic. Message content will be tailored to women and couples, and will range from health benefits of child spacing and an emphasis on contraceptive options, to the hierarchy of effectiveness and information on specific methods, to simple reminders about postpartum visits. Prior to randomization, each enrolled woman will be asked if she has a male partner, and whether she would like to refer her male partner for recruitment and enrollment into the study. The partner tracks are as follows:
|
NO_INTERVENTION: Control
The control arm will receive standard education and counseling provided in antenatal care and in postnatal care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Highly-effective contraceptive use
Time Frame: 6 months postpartum
|
Proportion of participants self-reporting use of oral contraceptive pills, injectable contraception, contraceptive implant, intrauterine device, or male/female sterilization at 6 months postpartum will be compared between arms.
Questionnaires will be used to assess this outcome.
|
6 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to contraceptive use
Time Frame: Through study completion (6 months postpartum)
|
Time postpartum at which contraceptive use was initiated
|
Through study completion (6 months postpartum)
|
Dual contraceptive use
Time Frame: 6 weeks, 14 weeks, and 6 months postpartum
|
Percentage of sexual acts in which a condom was used among contraceptive users
|
6 weeks, 14 weeks, and 6 months postpartum
|
Any contraceptive use
Time Frame: 6 weeks, 14 weeks, and 6 months postpartum
|
Proportion of participants self-reporting use of any contraceptive method will be compared between arms.
This outcome will be assessed with a questionnaire.
|
6 weeks, 14 weeks, and 6 months postpartum
|
Family planning satisfaction questionnaire
Time Frame: 6 weeks, 14 weeks, and 6 months postpartum
|
Satisfaction with chosen contraceptive method
|
6 weeks, 14 weeks, and 6 months postpartum
|
Exclusive breastfeeding questionnaire
Time Frame: 6 weeks, 14 weeks, and 6 months postpartum
|
Self-reported exclusive breastfeeding
|
6 weeks, 14 weeks, and 6 months postpartum
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
- Harrington EK, Drake AL, Matemo D, Ronen K, Osoti AO, John-Stewart G, Kinuthia J, Unger JA. An mHealth SMS intervention on Postpartum Contraceptive Use Among Women and Couples in Kenya: A Randomized Controlled Trial. Am J Public Health. 2019 Jun;109(6):934-941. doi: 10.2105/AJPH.2019.305051.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 51125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ); Essential Access HealthNot yet recruitingContraception | Contraception Behavior | Reproductive BehaviorUnited States
Clinical Trials on Two-way SMS
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya (Mobile WACh)Maternal Health | Family Planning | Neonatal HealthKenya
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedDepression | Perinatal Death | Neonatal DeathKenya
-
RANDCompletedHuman Immunodeficiency VirusUganda, United States
-
Women and Infants Hospital of Rhode IslandEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDepression | Perinatal Death | Neonatal DeathKenya
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingHiv | Contraception | Fertility IssuesKenya
-
Hacettepe UniversityCompleted
-
Cairo UniversityCompletedCervical Lordosis RehabilitationEgypt
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHypertension | Renal Insufficiency, ChronicUnited States
-
Mayo ClinicAdelante HealthcareCompleted
-
University of PennsylvaniaCompletedAlzheimer Disease | Genetic Predisposition to Disease